Carregant...
Favipiravir: A new and emerging antiviral option in COVID-19
With over 16 million cases reported from across the globe, the SARS-CoV-2, a mere 125 microns in diameter, has left an indelible impact on our world. With the paucity of new drugs to combat this disease, the medical community is in a race to identify repurposed drugs that may be effective against th...
Guardat en:
| Publicat a: | Med J Armed Forces India |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7467067/ https://ncbi.nlm.nih.gov/pubmed/32895599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2020.08.004 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|